SB 369 Requires reporting and creates crimes related to counterfeit, fake, diluted, or black market drugs
Sponsor: LeVota
LR Number: 1791S.02I Fiscal Note not available
Committee: Judiciary and Civil and Criminal Jurisprudence
Last Action: 2/28/2013 - Second Read and Referred S Judiciary and Civil and Criminal Jurisprudence Committee Journal Page: S401
Title: Calendar Position:
Effective Date: August 28, 2013

Full Bill Text | All Actions | Amendments/CCRs/CCSs | Available Summaries | Senate Home Page | List of 2013 Senate Bills

Current Bill Summary


SB 369 - Under this act, any person involved in the production, sale, distribution, or administration of prescription medications who has reason to suspect that counterfeit, fake, diluted, or black market drugs are being distributed must report, or cause a report to be made, within 7 business days to the Food and Drug Administration, the State Board of Pharmacy, or a law enforcement agency. Failure to make such a report is a Class A misdemeanor.

Any employee of a drug or pharmaceutical company that attempts to conceal information about suspected counterfeit, fake, diluted, or black market drugs, or any other drug being distributed that could result in death or serious physical injury is guilty of a Class D felony.

This act is similar to HB 592 (2013) and HB 1699 (2012).

MEGHAN LUECKE